Iovanace Biotherapeutics (IOVA) PT Lowered to $35 at Piper Sandler
Tweet
Share
E-mailGet Alerts IOVA Hot Sheet
Price: $8.43 -3.1%
Rating Summary:
8 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 98
Rating Summary:
8 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 98
Join SI Premium – FREE
Piper Sandler analyst Joseph Catanzaro lowered the price target on Iovanace Biotherapeutics (NASDAQ: IOVA) to $35.00 (from $45.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Macquarie Downgrades Mercari, Inc (4385:JP) (MRCIF) to Neutral
- JPMorgan Downgrades Arafura Rare Earths (ARU:AU) to Underweight
- J.Jill Inc. (JILL) PT Raised to $25 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
